Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Our work

The funding of Europa Uomo comes from small contributions from member organisations through their annual dues, contributions from partner organisations such as the European Association of Urologists (EAU) and the European School of Oncology (ESO), sponsorship from a number of pharmaceutical companies and cost reimbursement when representatives have attended meetings.

In accordance with Belgian law for not-for-profit organisations, annual financial reports are considered and approved by the Europa Uomo General Assembly.

Europa Uomo is compliant with EMA guidelines on the funding of recognised patient organisations, in terms of the number of supporting pharmaceutical companies and the requirement that it is not more than 50% dependent on any one source.

List of all funding sources (industry and non-industry) 2023

Overall proportion of industry and non-industry funding

The percentage of the highest contribution from one single company in terms of the overall income is 20.96%